Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer [Phase 2]
Phase 2 trial evaluating psilocybin-assisted existential therapy (PEARL) for patients with advanced cancers; the study is currently active b…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors [Phase 1]
Phase 1 trial update assessing the safety of hV01, a recombinant IL-21–expressing oncolytic vaccinia virus, in patients with advanced solid …
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: G-CSF-Induced Bone Pain and Supportive Care Approaches
This Clinical Trial Update discusses strategies to manage G-CSF-induced bone pain and evaluates supportive care approaches in a completed tr…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: First in Human Study of AZD9592 in Solid Tumors [Phase 1]
First-in-human Phase 1 study of AstraZeneca’s AZD9592 in solid tumors is recruiting to evaluate safety, tolerability, and preliminary dosing…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating immunoradiotherapy combinations for metastatic solid tumors has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults [EARLY_Phase 1]
A Phase 1 trial evaluating pembrolizumab in combination with decitabine and hypofractionated radiation in pediatric and young adult patients…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours [Phase 1]
A Phase 1 immuno-PET study of the radiolabeled tracer 89Zr-S095012 in patients with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Open-label, first-in-human dose-escalation and dose-expansion Phase I/II trial evaluating SPR1020 in patients with advanced solid tumors to …
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours [Phase 1]
This Phase 1 study evaluates the safety, tolerability, and pharmacokinetics of MSP008-22 in patients with advanced solid tumors. The trial s…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Screening Study for Participants With Malignant Tumors [Phase 2]
This entry notes the completion of a Phase 2 screening study for participants with malignant solid tumors sponsored by Hoffmann-La Roche. Th…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors [Phase 1, Phase 2]
A first-in-human trial of GEN1078 in participants with solid tumors spanning Phase 1/2 has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors [NA]
A completed clinical trial evaluating attention bias modification to reduce anxiety in adolescent and young adult cancer survivors.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Phase I Trial of VS-6766 Alone and in Combination With Everolimus [Phase 1]
Completed Phase I trial evaluating VS-6766 alone and in combination with everolimus in patients with solid tumors, multiple myeloma, lung ca…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors [Phase 1]
A Phase 1 study of SIM0505 in participants with advanced solid tumors is currently recruiting. The sponsor is NextCure, Inc.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake [Phase 1, Phase 2]
A Phase 1/2 trial of [177Lu]-NeoB and [68Ga]-neoB in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours [Phase 1]
Phase 1 trial evaluating a safe dose of BI 754091 in patients with solid tumors has completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: First in Human Study of SIM0610 in Solid Tumors [Phase 1]
A first-in-human Phase 1 study of SIM0610 in solid tumors is underway, evaluating safety and dosing across multiple indications including No…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP) [Phase 1]
A Phase 1 dose-escalation and cohort-expansion study of niraparib in combination with dostarlimab in pediatric patients with solid tumors ha…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy [Phase 1, Phase 2]
This clinical trial update reports results from Phase 1/2 studies evaluating whether statins influence the incidence of side effects, includ…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 dose-escalation and expansion trial of a SAR444200-based regimen in adults with advanced solid tumors; the study status is termina…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Intratumoral N17350 in Advanced Solid Tumors [Phase 1, Phase 2]
Update on the investigational intratumoral therapy N17350 being studied in advanced solid tumors in Phase 1 and Phase 2 trials, sponsored by…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors [Phase 1]
This clinical trial update reports the first-in-human Phase 1 study of JAB-8263 in adults with advanced solid tumors, which has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients [Phase 1, Phase 2]
This clinical trial update reports termination and posted results for a Phase 1/2 study of rintatolimod plus interferon alpha-2b in cancer p…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors [Phase 1, Phase 2]
This update reports the completion of a Phase I/II clinical trial evaluating XNW5004 tablets in patients with relapsed/refractory advanced s…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of ABBV-927 and ABBV-181 in participants with advanced solid tumors is active but not currently recruiting, with ongoing immun…